The Effects of Different Classes of Antihypertensive Drugs on Patients with COVID-19 and Hypertension: A Mini-Review.

IF 1.9 4区医学 Q3 PERIPHERAL VASCULAR DISEASE

International Journal of Hypertension Pub Date : 2022-01-21 eCollection Date: 2022-01-01 DOI:10.1155/2022/5937802

Farnoosh Nozari, Nasrin Hamidizadeh

引用次数: 7

Abstract

Hypertension is a major risk factor for cardiovascular disease. Previous studies showed that patients with hypertension are at an increased risk of developing severe COVID-19 infection. Therefore, proper blood pressure control in hypertensive patients with COVID-19 is of great importance. In this review, we discussed the effects of different classes of antihypertensive drugs on patients with hypertension and COVID-19.

查看原文本刊更多论文

不同类型降压药对COVID-19合并高血压患者的影响:一个小型综述。

高血压是心血管疾病的主要危险因素。先前的研究表明，高血压患者患严重新冠肺炎感染的风险增加。因此，正确控制新冠肺炎高血压患者的血压具有重要意义。在这篇综述中，我们讨论了不同类别的抗高血压药物对高血压和新冠肺炎患者的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Hypertension Medicine-Internal Medicine

CiteScore

4.00

自引率

5.30%

发文量

期刊介绍： International Journal of Hypertension is a peer-reviewed, Open Access journal that provides a forum for clinicians and basic scientists interested in blood pressure regulation and pathophysiology, as well as treatment and prevention of hypertension. The journal publishes original research articles, review articles, and clinical studies on the etiology and risk factors of hypertension, with a special focus on vascular biology, epidemiology, pediatric hypertension, and hypertensive nephropathy.